Register for your FREE account now and join thousands of oncology professionals who stay informed about patient care issues, practical oncology-care management techniques, and drug administration and dosage information.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Breast Cancer

Melanoma genome study implicates sun and new genetic culprits

Delicia Honen Yard May 28, 2012

Genetic mutations increased along with chronic sun exposure in persons with melanoma, and yet another gene may contribute to disease risk as well.
 

The link between diabetes and breast cancer

Ajay K. Malik, PhD May 25, 2012

The earliest link between diabetes and cancer was alluded to in the 1930s. However, convincing epidemiological evidence has emerged only recently, proving an association between diabetes and cancer.
 

Physical activity linked to lower breast, colon cancer death rates

May 24, 2012

Consistent evidence from 27 observational studies demonstrated a link between exercise and reduced all-cause mortality for breast, colon cancers.
 

Coping with Side Effects of Breast Cancer Treatment

May 22, 2012

Women with breast cancer have many treatment options. This patient fact sheet details the side effects of these treatments and ways to cope.
 

Cancer pain often undertreated, especially among minorities

Delicia Honen Yard May 16, 2012

One-third of outpatients with breast, prostate, colon/rectum, or lung cancer were receiving insufficient pain treatment, particularly minorities.
 

Potentially treatable side effects plague breast cancer survivors for years

Delicia Honen Yard May 11, 2012

Six years after breast cancer treatment, more than 60% of women experienced at least one side effect amenable to rehabilitative intervention.
 

Review: Physical activity cuts mortality for cancer survivors

May 10, 2012

Consistent evidence for benefit of exercise on all-cause, breast and colon cancer-specific mortality.
 

ASBS: Mammography beats infrared screening for breast cancer

May 07, 2012

No Touch Breast Scan has poor sensitivity or specificity depending on the mode.
 

Screening benefits women in 40s with high breast cancer risk

May 01, 2012

And, extremely dense breasts, first-degree relative with breast cancer ups risk two-fold in 40s
 

A second gene may predispose women to breast cancer

April 30, 2012

Scientists have discovered that the Abraxas gene may advance the mission of BRCA1 and may even act on its own to help breast cancer develop.
 

IMRT shows better side-effect profile in breast cancer

Delicia Honen Yard April 30, 2012

Intensity-modulated radiation therapy is associated with fewer toxicities than is the standard approach of whole breast irradiation.
 

Excessive neutropenia for weekly wverolimus + docetaxel

April 27, 2012

Dose-limiting neutropenia, variable drug clearance for patients with metastatic breast cancer.
 

Cancer worry linked to continued symptom burden

April 27, 2012

Age, fatigue, and risk perception also significantly associated with lingering cancer worry.
 

Mutations in XRCC2 gene tied to breast cancer risk

Delicia Honen Yard April 26, 2012

Mutations in a gene called XRCC2 have been linked to breast cancer susceptibility in families with none of the currently known breast-risk genes.
 

EB: Cadmium exposure tied to breast cancer progression

April 24, 2012

Chronic exposure increases MCF-7 cell migration and invasion through extracellular matrix.
 

New marker flags DNA repair response to platinum therapy

Delicia Honen Yard April 24, 2012

A new marker of DNA damage may predict which triple-negative breast cancers or serous ovarian cancers will respond to platinum-based chemotherapy.
 

New fat grafting procedures improve breast reconstruction

April 23, 2012

Enhanced stromal vascular fraction and platelet-rich plasma grafting maintain volume, 3D contour.
 

Stress management boosts immune system in breast cancer

Delicia Honen Yard April 23, 2012

A stress-management program for women with breast cancer can alter tumor-promoting processes at the molecular level, according to researchers.
 

Opioids may spur tumor growth

Delicia Honen Yard April 20, 2012

Although opioid-based painkillers are a standard treatment for relieving cancer pain, they may actually contribute to disease progression.
 

Managing side effects of tamoxifen

April 18, 2012

What is the risk for endometrial cancer in a patient taking tamoxifen to reduce recurrence of ER/PR positive breast cancer after treatment?
 

VEGF blockade: Optimizing chemotherapy drug uptake

April 17, 2012

New research is showing that sequence and timing have significant impact on the efficacy of therapeutic regimens that include bevacizumab.
 

On-site lab 
reduces repeat surgeries

April 17, 2012

A new service has helped reduce the number of women who need additional surgery after an initial resection for breast cancer.
 

Diagnosis delayed for certain cancers and certain patients

April 17, 2012

A large UK study found a wide variation between cancer types in patients who had visited their general practitioner 3 or more times before cancer diagnosis.
 

SBM: Decision aid helps breast cancer-related decision-making

April 16, 2012

Web-based decision aid lowers decisional conflict, helps women decide about prophylactic treatment.
 

Women confused by DCIS breast diagnosis

Delicia Honen Yard April 16, 2012

Ductal carcinoma in situ has a positive prognosis but requires treatment similar to that for invasive breast cancer, sending a conflicting message.
 

Most breast cancer survivors experience lasting side effects

April 13, 2012

Proportion experiencing side effects remains stable from 12 months to 6 years post-diagnosis.
 

Perception of breast cancer care differs from actual care quality

April 12, 2012

Study focuses on women from inner cities with newly diagnosed, early-stage breast cancer.
 

Many women with cancer missing fertility risk info, services

Delicia Honen Yard April 11, 2012

Few women of childbearing age who are diagnosed with cancer are taking steps to preserve their fertility during treatment.
 

Injectable contraceptive linked to elevated breast cancer risk

April 11, 2012

Recent use of depo-medroxyprogesterone acetate for 12 months or longer may double the risk of breast cancer.
 

Web Exclusives

Posttransplant lenalidomide can slow down multiple myeloma

Delicia Honen Yard May 29, 2012

Lenalidomide use after autologous stem-cell transplant significantly improved progression-free and overall survival in patients with myeloma.
 

Melanoma genome study implicates sun and new genetic culprits

Delicia Honen Yard May 28, 2012

Genetic mutations increased along with chronic sun exposure in persons with melanoma, and yet another gene may contribute to disease risk as well.
 

Modified stem cells keep glioblastoma at bay

Delicia Honen Yard May 25, 2012

Three patients with glioblastoma lived longer than predicted after receiving transplants of their own blood stem cells that had been gene-modified.
 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions